%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/sljcon/public/qrxcgw/cache/
Upload File :
Create Path :
Current File : /var/www/html/sljcon/public/qrxcgw/cache/8187894479a59f59985af584e76b71d8

a:5:{s:8:"template";s:8340:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<meta content="yes" name="apple-mobile-web-app-capable"/>
<meta content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no" name="viewport"/>
<link href="http://fonts.googleapis.com/css?family=Raleway%3A100%2C200%2C300%2C400%2C500%2C600%2C700%2C800%2C900%7COpen+Sans%3A300%2C400%2C600%2C700%2C800%2C300italic%2C400italic%2C600italic%2C700italic%2C800italic&amp;subset=latin&amp;ver=4.3.21" id="redux-google-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@charset "utf-8"; html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,header,section{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{text-shadow:none!important;color:#000!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Open Sans","Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#666;background-color:#efefef}a{color:#cc1b5f;text-decoration:none}a:focus,a:hover{color:#881240;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.row{margin-left:-15px;margin-right:-15px}.col-md-4,.col-sm-4{position:relative;min-height:1px;padding-left:15px;padding-right:15px}@media (min-width:768px){.col-sm-4{float:left}.col-sm-4{width:33.33333333%}}@media (min-width:992px){.col-md-4{float:left}.col-md-4{width:33.33333333%}}label{display:inline-block;margin-bottom:5px;font-weight:700}  .caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px solid;border-right:4px solid transparent;border-left:4px solid transparent}.container:after,.container:before,.row:after,.row:before{content:" ";display:table}.container:after,.row:after{clear:both}@-ms-viewport{width:device-width} body{-webkit-font-smoothing:antialiased;overflow-x:hidden}a:active,a:focus,a:hover{text-decoration:none}a:focus{outline:0}.menu_container>ul>li:hover>a{color:#cc1b5f!important}.mobile_collapser{background-color:#cc1b5f!important}header{font-family:Raleway,"Helvetica Neue",Helvetica,Arial,sans-serif;background:0 0;position:relative;top:0;left:0;right:0;z-index:1;-webkit-box-shadow:0 0 2px 0 rgba(0,0,0,.5);-moz-box-shadow:0 0 2px 0 rgba(0,0,0,.5);box-shadow:0 0 2px 0 rgba(0,0,0,.5)}footer{color:#fff;background:none #222}footer a:link,footer a:visited{color:#cc1b5f}footer a:active,footer a:hover{color:#881240;text-decoration:none}.copyright{border-top:solid 1px #000;padding:15px 0;background-color:rgba(0,0,0,.5);font-weight:300;color:#999;font-size:13px}@media (min-width:992px) and (max-width:1199px){.menu_container{margin:26px 0!important}}@media only screen and (max-width:991px){header{-webkit-box-shadow:0 0 2px 0 rgba(0,0,0,.5)!important;-moz-box-shadow:0 0 2px 0 rgba(0,0,0,.5)!important;box-shadow:0 0 2px 0 rgba(0,0,0,.5)!important}header .container{padding-left:0;padding-right:0;-webkit-box-shadow:0 0 0 0 transparent!important;-moz-box-shadow:0 0 0 0 transparent!important;box-shadow:0 0 0 0 transparent!important;text-align:center}header .menu_container{margin:0;float:none}header .menu_container>ul{float:left;text-align:center;display:block}header .menu_container>ul>li{display:inline-block;float:none}header .menu_container>ul>li a{padding-top:12px}}@media only screen and (max-width:767px){body{margin:0;padding:0}header .menu_container{margin:15px 0 0 0}header .menu_container>ul{background-color:#fff}header .menu_container>ul li{display:block}}@media only screen and (max-width:480px){.copyright{height:70px!important}.infobar_copyright{text-align:center}}body,html{height:100%} .menu_container{margin-top:0;background:0 0;background-color:#fff;float:none;width:100%;z-index:100;box-sizing:border-box;-moz-box-sizing:border-box;padding:0;height:auto}.menu_container>ul{background:inherit;list-style:none;margin:0;padding:0;float:none;position:relative;width:100%;height:0;transition:all .1s linear;-moz-transition:all .1s linear;-o-transition:all .1s linear;-webkit-transition:all .1s linear;overflow:hidden}.menu_container>ul>li{display:block;float:none;padding:0;margin:0}.menu_container>ul>li>a{padding:15px 15px;margin:1px 0;display:block;color:#777;text-decoration:none;font-size:13px;line-height:18px;font-weight:500;border-bottom:solid 0 #ccc;background-color:#fff;text-transform:uppercase}.menu_container>ul>li:hover>a{border-bottom:solid 0 #428bca}.mobile_collapser{display:block;height:51px;text-align:left;padding:12px 25px;color:#fff;font-size:16px;line-height:22px;background-color:#428bca;border-bottom:solid 1px #216aa5;margin-bottom:0}.mobile_collapser:before{content:'\2261';display:block;float:left;margin:-1px 8px 0 2px;font-size:30px}@media only screen and (min-width:768px){.mobile_collapser{display:none}.menu_container{float:right;clear:none;margin:29px 0;background:0 0;position:relative;top:0;left:0;width:auto}.menu_container>ul{background:0 0;height:inherit;overflow:visible}.menu_container>ul>li{float:left;background:inherit;width:auto;border-left:solid 0 #ccc;text-align:left;position:relative}.menu_container>ul>li>a{padding:12px 12px;margin:0 3px;display:block;color:#555;text-decoration:none;font-size:13px;line-height:18px;font-weight:800;background-color:transparent}}@media (min-width:992px) and (max-width:1199px){.menu_container>ul>li>a{padding:15px 10px;margin:0 3px}}@media (min-width:768px) and (max-width:991px){.menu_container{float:none;clear:both;margin:0 0 20px 0}.menu_container>ul>li>a{padding:15px 10px;margin:0 3px}} .container:after,.container:before,.row:after,.row:before{content:" ";display:table}.container:after,.row:after{clear:both} @font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFVZ0e.ttf) format('truetype')} @font-face{font-family:Raleway;font-style:normal;font-weight:400;src:local('Raleway'),local('Raleway-Regular'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptug8zYS_SKggPNyC0ISg.ttf) format('truetype')}@font-face{font-family:Raleway;font-style:normal;font-weight:500;src:local('Raleway Medium'),local('Raleway-Medium'),url(http://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwN4rWqZPBQ.ttf) format('truetype')}</style>
 </head>
 <body><div id="fb-root"></div>
<div class="overflow_wrapper">
<header>
<div class="container">
<a class="brand" href="#">
<h2>
{{ keyword }}
</h2>
</a>
<div class="menu_container" id="mainmenu">
<label class="mobile_collapser">MENU</label> 
<ul class="" id="menu-main-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1911" id="menu-item-1911"><a href="#" title="About">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1910" id="menu-item-1910"><a href="#" title="Blog">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item-1951 " id="menu-item-1951"><a href="#" title="Service">Service<span class="caret"></span></a>
</li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1906" id="menu-item-1906"><a href="#" title="Contacts">Contacts</a></li>
</ul> </div>
</div>
</header>
{{ text }}
<br>
<br>
{{ links }}
<footer>
<section class="footer_teasers_wrapper dark_section">
<div class="container">
<div class="row">
</div>
</div>
</section>
<div class="copyright"> <div class="container"> <div class="row"> <div class="col-sm-4 col-md-4 infobar_copyright"><a href="#">{{ keyword }} 2021</a> </div> </div> </div> </div> </footer>
</div>
</body></html>";s:4:"text";s:3742:"Survival rates also depend on other factors, including how far the tumor has spread. In about 25% of cases, the cancer has already spread to other parts of the body at the time of diagnosis. Visit the individual section for a specific type of childhood cancer for more information about survival statistics (see the Introduction for a complete list). [] For rhabdomyosarcoma, the 5-year survival rate increased over the same time, from 53% to 67% for children younger than 15 years and from 30% to 51% for adolescents aged 15 to 19 years. The overall 5-year survival rate for people with a Ewing tumor is 62%. For soft tissue sarcomas, 5-year survival rates in 2008–2014 among children and adolescents ages 0 to 19 years ranged from 65% (rhabdomyosarcoma) to 95% (chondrosarcoma) , but children with sarcomas who present with metastatic disease have much lower 5-year survival rates. Upon acceptance, the accepted manuscript will be posted on the journal website.  The survival rate in this group is generally around 20% to 30%. If it has spread to the nearby region (called regional), the 5-year survival rate is 67%. The Journal of Pediatrics encourages submissions relating to the scientific and health policy implications of the current COVID-19 pandemic that are specific to infants, children, and adolescents. [] Between 1975 and 2010, childhood cancer mortality decreased by more than 50%. Again, it’s important to note that other factors, such as the patient’s age and the location and type of tumor can affect these numbers. Whether you or someone you love has cancer, knowing what to expect can help you cope. We are pleased to announce a new free Case Based Urology Learning Program from the Cleveland Clinic Glickman Urological and Kidney Institute, Rainbow Babies and Children’s Hospital, and University Hospitals Case Medical Center. The 5-year relative survival rate for all cancers combined diagnosed during 2010 through 2016 was 67% overall, 68% in White individuals, and 63% in Black individuals. [] Editor/authors are masked to the peer review process and editorial decision-making of their own work and are not able to access this work in the online manuscript submission system. The most common areas where it begins are the legs, pelvis, and chest wall. After desk review, manuscripts related to COVID-19 chosen for peer review will undergo rapid review. Continual improvements in survival have been achieved for children and adolescents with cancer. Rhabdomyosarcoma (RMS), is a highly aggressive form of cancer that develops from mesenchymal cells that have failed to fully differentiate into myocytes of skeletal muscle.Cells of the tumor are identified as rhabdomyoblasts.. Ewing sarcoma is a type of cancer that may be a bone sarcoma or a soft-tissue sarcoma. From basic information about cancer and its causes to in-depth information on specific cancer types – including risk factors, early detection, diagnosis, and treatment options – you’ll find it here. Symptoms may include swelling and pain at the site of the tumor, fever, and a bone fracture. 6 Figure 4 shows 5-year relative survival rates for selected cancer types by stage at diagnosis and race. For teens age 15 to 19, the 5-year survival rate for all cancers is 85%. There are four subtypes – embryonal rhabdomyosarcoma, alveolar rhabdomyosarcoma, pleomorphic rhabdomyosarcoma, and spindle cell/sclerosing rhabdomyosarcoma. AJOG's Editors have active research programs and, on occasion, publish work in the Journal. If the tumor is found only in the area it began (called localized), the 5-year survival rate is 82%. It is important to remember that statistics on the survival rates for children and teens with cancer are an estimate. ";s:7:"keyword";s:40:"childhood rhabdomyosarcoma survival rate";s:5:"links";s:953:"<a href="http://sljco.coding.al/qrxcgw/restaurants-for-sale-wyoming">Restaurants For Sale Wyoming</a>,
<a href="http://sljco.coding.al/qrxcgw/manitoba-m%C3%A9tis-covid-vaccine">Manitoba Métis Covid Vaccine</a>,
<a href="http://sljco.coding.al/qrxcgw/isla-sorna-aviary-gold-bricks">Isla Sorna Aviary Gold Bricks</a>,
<a href="http://sljco.coding.al/qrxcgw/ontic-technologies-news">Ontic Technologies News</a>,
<a href="http://sljco.coding.al/qrxcgw/east-high-school-state-championship">East High School State Championship</a>,
<a href="http://sljco.coding.al/qrxcgw/new-scholarship-2021-in-pakistan">New Scholarship 2021 In Pakistan</a>,
<a href="http://sljco.coding.al/qrxcgw/formula-1-sponsorship-cost">Formula 1 Sponsorship Cost</a>,
<a href="http://sljco.coding.al/qrxcgw/georgian-court-student-success">Georgian Court Student Success</a>,
<a href="http://sljco.coding.al/qrxcgw/uf-scholarship-thank-you-letter">Uf Scholarship Thank You Letter</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0